The role of race and economic characteristics in the presentation and survival of patients with surgically-resected non-small cell lung cancer.

e20053 Background: To investigate the inter-relation between economic, marital, and known histopathologic/therapeutic prognostic factors in presentation and survival of surgically-resected lung cancer patients in nine different ethnic groups. Methods: A retrospective review of the SEER database was conducted through the years 2007-2012. Population differences were assessed via chi-square testing. Multivariable analyses(MVA) were used to detect overall survival(OS) differences in the total surgical population (TS, N = 35,689) and in an early-stage (T1-T2 < 4cm N0) surgically-resectable population(ESR, N = 17,931). Results: In the TS population, as compared to Whites, Blacks and Hispanics were more likely to present with younger age, adenocarcinomas, less married partnerships, no insurance, fewer stage I tumors, and fewer nodes examined, but their surgical procedure types and OS/LCSS were the same. MVA demonstrated that lower OS was associated with males, single/divorced/widowed partnership, lower income(TS only), and Medicaid insurance. MVA also found that all ethnic groups had a similar (Hispanics, Blacks) or better OS compared to Whites. 90-day mortality and positive nodes were correlated with not having insurance and not being married, but not ethnicity. Conclusions: In TS and ESR groups, OS was not different in the two largest ethnic groups (Black, Hispanic) as compared to Whites, but was related to single/widowed/divorced status, Medicaid insurance, and income (TS group only). Nodal positivity was associated with patients who did not have a married partner or insurance suggesting that psycho-social variables may impact disease biology in addition to the known histopathologic and treatment variables in patients undergoing surgical resection of early-stage lung cancer.

Download Full-text

Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients

10.1183/13993003.congress-2021.pa2293 ◽

2021 ◽

Author(s):

Jonathan Groves ◽

Ryan Yeo ◽

Yat Tsang ◽

Nihal Shah ◽

Thida Win

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Clinical Outcomes ◽

Early Stage ◽

Early Stage Lung Cancer ◽

Lung Cancer Patients ◽

Stereotactic Ablative Body Radiotherapy ◽

Stage Lung Cancer

Download Full-text

Torque Teno Virus load in lung cancer patients correlates with age but not with tumor stage

PLoS ONE ◽

10.1371/journal.pone.0252304 ◽

2021 ◽

Vol 16 (6) ◽

pp. e0252304

Author(s):

Dirk Stefani ◽

Balazs Hegedues ◽

Stephane Collaud ◽

Mohamed Zaatar ◽

Till Ploenes ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Early Stage ◽

Stage Iv ◽

Tumor Stage ◽

Plasma Dna ◽

Early Stage Lung Cancer ◽

Lung Cancer Patients ◽

Stage Iv Lung Cancer ◽

Stage Lung Cancer

Background Torque teno virus (TTV) is a ubiquitous non-pathogenic virus, which is suppressed in immunological healthy individuals but replicates in immune compromised patients. Thus, TTV load is a suitable biomarker for monitoring the immunosuppression also in lung transplant recipients. Since little is known about the changes of TTV load in lung cancer patients, we analyzed TTV plasma DNA levels in lung cancer patients and its perioperative changes after lung cancer surgery. Material and methods Patients with lung cancer and non-malignant nodules as control group were included prospectively. TTV DNA levels were measured by quantiative PCR using DNA isolated from patients plasma and correlated with routine circulating biomarkers and clinicopathological variables. Results 47 patients (early stage lung cancer n = 30, stage IV lung cancer n = 10, non-malignant nodules n = 7) were included. TTV DNA levels were not detected in seven patients (15%). There was no significant difference between the stage IV cases and the preoperative TTV plasma DNA levels in patients with early stage lung cancer or non-malignant nodules (p = 0.627). While gender, tumor stage and tumor histology showed no correlation with TTV load patients below 65 years of age had a significantly lower TTV load then older patients (p = 0.022). Regarding routine blood based biomarkers, LDH activity was significantly higher in patients with stage IV lung cancer (p = 0.043), however, TTV load showed no correlation with LDH activity, albumin, hemoglobin, CRP or WBC. Comparing the preoperative, postoperative and discharge day TTV load, no unequivocal pattern in the kinetics were. Conclusion Our study suggest that lung cancer has no stage dependent impact on TTV plasma DNA levels and confirms that elderly patients have a significantly higher TTV load. Furthermore, we found no uniform perioperative changes during early stage lung cancer resection on plasma TTV DNA levels.

Download Full-text

Comparison of Wedge Resection Versus Wedge Resection Plus Cesium-131 Brachytherapy Versus Stereotactic Body Radiation Therapy in Management of Early Stage Lung Cancer Patients That Are Not Candidates for a Standard Lobectomy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.06.525 ◽

2013 ◽

Vol 87 (2) ◽

pp. S203-S204 ◽

Cited By ~ 1

Author(s):

B. Parashar ◽

S. Arora ◽

P. Christos ◽

J. Port ◽

A. Wernicke ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Cancer Patients ◽

Stereotactic Body Radiation Therapy ◽

Early Stage ◽

Wedge Resection ◽

Early Stage Lung Cancer ◽

Lung Cancer Patients ◽

Stereotactic Body Radiation ◽

Stage Lung Cancer

Download Full-text

Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-stage Lung Cancer Diagnosis

10.21203/rs.3.rs-97860/v1 ◽

2020 ◽

Author(s):

Lingling Wan ◽

Yutong He ◽

Qingyi Liu ◽

Di Liang ◽

Yongdong Guo ◽

...

Keyword(s):

Lung Cancer ◽

Early Diagnosis ◽

Cancer Patients ◽

Early Stage ◽

Untargeted Metabolomics ◽

Early Stage Lung Cancer ◽

Lung Cancer Patients ◽

Diagnosis Of Lung Cancer ◽

Metabolomics Analysis ◽

Stage Lung Cancer

Abstract Background: Lung cancer is a malignant tumor that has the highest morbidity and mortality rate among all cancers. Early diagnosis of lung cancer is a key factor in reducing mortality and improving prognosis. Methods: In this study, we performed CTC next-generation sequencing (NGS) in early-stage lung cancer patients to identify lung cancer-related gene mutations. Meanwhile, a serum liquid chromatography-tandem mass spectrometry (LC-MS) untargeted metabolomics analysis was performed in the CTC-positive patients, and the early diagnostic value of these assays in lung cancer was analyzed. Results: 62.5% (30/48) of lung cancer patients had ≥ 1 CTC. By CTC NGS, we found that > 50% of patients had 4 commonly mutated genes, namely, NOTCH1, IGF2, EGFR, and PTCH1. 47.37% (9/19) patients had ARIDH1 mutations. Additionally, 30 CTC-positive patients and 30 healthy volunteers were subjected to LC-MS untargeted metabolomics analysis. We found 100 different metabolites, and 10 different metabolites were identified through analysis, which may have potential clinical application value in the diagnosis of CTC-positive early-stage lung cancer (AUC > 0.9). Conclusions: Our results indicate that NGS of CTC and metabolomics may provide new tumor markers for the early diagnosis of lung cancer. This possibility requires more in-depth large-sample research for verification.

Download Full-text